Skip to main content
All lobbying filings

FORBES-TATE

Lobbying for CALIFORNIA LIFE SCIENCES ASSOCIATION · Trade association representing Californias innovative life sciences ecosystem

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $40,000.00 income · posted Apr 17, 2026

Official filing document

 Lobbying activity 7
Health Issues

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.

Manufacturing

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Medical/Disease Research/Clinical Labs

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Medicare/Medicaid

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers; Issues related to transitional coverage of emerging technologies.

Pharmacy

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.

Taxation/Internal Revenue Code

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Trade (domestic/foreign)

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem